1. Asanuma K, Tanida I, Shirato I, Ueno T, Takahara H, Nishitani T, et al.: MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J 17: 1165–1167, 2003 10.1096/fj.02-0580fje
2. Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, et al.: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084–1096, 2010 10.1172/JCI39492
3. Oliva Trejo JA, Asanuma K, Kim EH, Takagi-Akiba M, Nonaka K, Hidaka T, et al.: Transient increase in proteinuria, poly-ubiquitylated proteins and ER stress markers in podocyte-specific autophagy-deficient mice following unilateral nephrectomy. Biochem Biophys Res Commun 446: 1190–1196, 2014 10.1016/j.bbrc.2014.03.088
4. Sakao Y, Kawai T, Takeuchi O, Copeland NG, Gilbert DJ, Jenkins NA, et al.: Mouse proteasomal ATPases Psmc3 and Psmc4: Genomic organization and gene targeting. Genomics 67: 1–7, 2000 10.1006/ geno.2000.6231
5. Tashiro Y, Urushitani M, Inoue H, Koike M, Uchiyama Y, Komatsu M, et al.: Motor neuron- specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem 287: 42984–42994, 2012 10.1074/jbc.M112.417600
6. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Podocytespecific expression of cre recombinase in transgenic mice. Genesis 35: 39–42, 2003 10.1002/gene.10164
7. Yamamoto-Nonaka K, Koike M, Asanuma K, Takagi M, Oliva Trejo JA, Seki T, et al.: Cathepsin D in podocytes is important in the pathogenesis of proteinuria and CKD. J Am Soc Nephrol 27: 2685–2700, 2016 10.1681/ASN.2015040366
8. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, et al.: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621–1629, 2001 10.1172/JCI200112849
9. Shirata N, Ihara K-I, Yamamoto-Nonaka K, Seki T, Makino SI, Oliva Trejo JA, et al.: Glomerulosclerosis induced by deficiency of membraneassociated guanylate kinase inverted 2 in kidney podocytes. J Am Soc Nephrol 28: 2654–2669, 2017 10.1681/ASN.2016121356
10. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, et al.: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248– 258, 1997 10.1006/excr.1997.3739
11. Ueno1 T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, et al.: Aberrant Notch1- dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int 83: 1065–1075, 2013 10.1038/ki.2013.48
12. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, et al.: Impairment of starvation- induced and constitutive autophagy in Atg7- deficient mice. J Cell Biol 169: 425–434, 2005 10.1083/jcb.200412022
13. Asanuma K, Akiba-Takagi M, Kodama F, Asao R, Nagai Y, Lydia A, et al.: Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy. Am J Nephrol 33: 537–549, 2011 10.1159/000327995
14. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, et al.: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957–968, 2001 10.1046/j.1523- 1755.2001.060003957.x
15. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, et al.: Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168: 42–54, 2006 10.2353/ajpath.2006.050398
16. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005– 3015, 2002 10.1097/ 01.ASN.0000039661.06947.FD
17. Gavilán E, Pintado C, Gavilan MP, Daza P, Sánchez-Aguayo I, Castaño A, et al.: Age-related dysfunctions of the autophagy lysosomal pathway in hippocampal pyramidal neurons under proteasome stress. Neurobiol Aging 36: 1953–1963, 2015 10.1016/ j.neurobiolaging.2015.02.025
18. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, et al.: HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447: 859–863, 2007 10.1038/nature05853
19. Mizushima N, Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 3: 542–545, 2007 10.4161/auto.4600
20. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G: The hallmarks of aging. Cell 153: 1194–1217, 2013 10.1016/ j.cell.2013.05.039
21. Chondrogianni N, Gonos ES: Proteasome dysfunction in mammalian aging: Steps and factors involved. Exp Gerontol 40: 931–938, 2005 10.1016/j.exger.2005.09.004
22. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y: In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15: 1101–1111, 2004 10.1091/mbc.E03
23. Kruse J-P, Gu W: Modes of p53 regulation. Cell 137: 609–622, 2009 10.1016/j.cell.2009.04.050
24. Thomasova D, Bruns HA, Kretschmer V, Ebrahim M, Romoli S, Liapis H, et al.: Murine double minute-2 prevents p53-overactivation-related cell death (podoptosis) of podocytes. J Am Soc Nephrol 26: 1513–1523, 2015 10.1681/ASN.2014040345
25. Acharya P, Engel JC, Correia MA: Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA- dependent protein kinase-like ER-bound eukaryotic initiation factor 2a (eIF2a)-kinase (PERK) and general control nonderepressible-2 eIF2a kinase (GCN2), and global translational shutoff. Mol Pharmacol 76: 503–515, 2009 10.1124/mol.109.056002
26. Otoda T, Takamura T, Misu H, Ota T, Murata S, Hayashi H, et al.: Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver. Diabetes 62: 811–824, 2013 10.2337/db11-1652
27. Guo C, Liu Y, Zhao W, Wei S, Zhang X, Wang W, et al.: Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities. J Cell Mol Med 19: 2273– 2285, 2015 10.1111/ jcmm.12619
28. Beeken M, Lindenmeyer MT, Blattner SM, Radón V, Oh J, Meyer TN, et al.: Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases. J Am Soc Nephrol 25: 2511–2525, 2014 10.1681/ASN.2013050522
29. Inoki K: mTOR signaling in autophagy regulation in the kidney. Semin Nephrol 34: 2–8, 2014 10.1016/j.semnephrol.2013.11.002.mTOR
30. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W: Neuroprotection of rapamycin in lactacystin- induced neurodegeneration via autophagy enhancement. Neurobiol Dis 32: 16–25, 2008 10.1016/ j.nbd.2008.06.003
31. Keller JN, Hanni KB, Markesbery WR: Possible involvement of proteasome inhibition in aging: Implications for oxidative stress. Mech Ageing Dev 113: 61–70, 2000 10.1016/S0047- 6374(99)00101-3
32. Cui J, Bai XY, Shi S, Cui S, Hong Q, Cai G, et al.: Age-related changes in the function of autophagy in rat kidneys. Age (Dordr) 34: 329–339, 2012 10.1007/s11357-011-9237-1
33. Tomaru U, Takahashi S, Ishizu A, Miyatake Y, Gohda A, Suzuki S, et al.: Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol 180: 963–972, 2012 10.1016/j.ajpath.2011.11.012
34. Keller JN, Hanni KB, Markesbery WR: Impaired proteasome function in Alzheimer’s disease. J Neurochem 75: 436–439, 2000 10.1046/j.1471- 4159.2000.0750436.x
35. Jenner P: Parkinson’s disease, pesticides and mitochondrial dysfunction. Trends Neurosci 24: 245–247, 2001
36. Myeku N, Duff KE: Targeting the 26S proteasome to protect against proteotoxic diseases. Trends Mol Med 24: 18–29, 2018 10.1016/ j.molmed.2017.11.006.Targeting